TrialInternational journal of hematology2022

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial.

Hirohisa Nakamae et al.PubMed ↗Publisher ↗

No numbers read from the abstract.